Dispenza MC - Search Results

1

Bruton's tyrosine kinase inhibition effectively protects against human IgE-mediated anaphylaxis.

Dispenza MC, Krier-Burris RA, Chhiba KD, Undem BJ, Robida PA, Bochner BS. Dispenza MC, et al. J Clin Invest. 2020 Sep 1;130(9):4759-4770. doi: 10.1172/JCI138448. J Clin Invest. 2020. PMID: 32484802 Free PMC article.

2

Ibrutinib, a Bruton's tyrosine kinase inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil activation test reactivity.

Regan JA, Cao Y, Dispenza MC, Ma S, Gordon LI, Petrich AM, Bochner BS. Regan JA, et al. Among authors: dispenza mc. J Allergy Clin Immunol. 2017 Sep;140(3):875-879.e1. doi: 10.1016/j.jaci.2017.03.013. Epub 2017 Apr 4. J Allergy Clin Immunol. 2017. PMID: 28389390 Free PMC article. No abstract available.

3

Potential applications of Bruton's tyrosine kinase inhibitors for the prevention of allergic reactions.

Dispenza MC, Regan JA, Bochner BS. Dispenza MC, et al. Expert Rev Clin Immunol. 2017 Oct;13(10):921-923. doi: 10.1080/1744666X.2017.1370374. Epub 2017 Aug 31. Expert Rev Clin Immunol. 2017. PMID: 28829205 Free PMC article. No abstract available.

4

Short-term ibrutinib therapy suppresses skin test responses and eliminates IgE-mediated basophil activation in adults with peanut or tree nut allergy.

Dispenza MC, Pongracic JA, Singh AM, Bochner BS. Dispenza MC, et al. J Allergy Clin Immunol. 2018 May;141(5):1914-1916.e7. doi: 10.1016/j.jaci.2017.12.987. Epub 2018 Jan 31. J Allergy Clin Immunol. 2018. PMID: 29360526 Free PMC article. No abstract available.

5

Diagnosis and Novel Approaches to the Treatment of Hypereosinophilic Syndromes.

Dispenza MC, Bochner BS. Dispenza MC, et al. Curr Hematol Malig Rep. 2018 Jun;13(3):191-201. doi: 10.1007/s11899-018-0448-8. Curr Hematol Malig Rep. 2018. PMID: 29680938 Free PMC article. Review.

6

Targeting the FcεRI Pathway as a Potential Strategy to Prevent Food-Induced Anaphylaxis.

Dispenza MC, Bochner BS, MacGlashan DW Jr. Dispenza MC, et al. Front Immunol. 2020 Dec 17;11:614402. doi: 10.3389/fimmu.2020.614402. eCollection 2020. Front Immunol. 2020. PMID: 33391286 Free PMC article. Review.

7

The Use of Bruton's Tyrosine Kinase Inhibitors to Treat Allergic Disorders.

Dispenza MC. Dispenza MC. Curr Treat Options Allergy. 2021;8(3):261-273. doi: 10.1007/s40521-021-00286-y. Epub 2021 Apr 16. Curr Treat Options Allergy. 2021. PMID: 33880321 Free PMC article. Review.

8

Bruton's tyrosine kinase inhibition for the prevention of anaphylaxis: an open-label, phase 2 trial.

Suresh RV, Dunnam C, Vaidya D, Wood RA, Bochner BS, MacGlashan DW Jr, Dispenza MC. Suresh RV, et al. Among authors: dispenza mc. Res Sq [Preprint]. 2023 Apr 5:rs.3.rs-2757218. doi: 10.21203/rs.3.rs-2757218/v1. Res Sq. 2023. Update in: J Clin Invest. 2023 Aug 15;133(16):e172335. doi: 10.1172/JCI172335. PMID: 37066249 Free PMC article. Updated. Preprint.

9

Research Advances in Mast Cell Biology and Their Translation Into Novel Therapies for Anaphylaxis.

Dispenza MC, Metcalfe DD, Olivera A. Dispenza MC, et al. J Allergy Clin Immunol Pract. 2023 Jul;11(7):2032-2042. doi: 10.1016/j.jaip.2023.03.015. Epub 2023 Mar 21. J Allergy Clin Immunol Pract. 2023. PMID: 36958519 Free PMC article. Review.

10

A Skin Testing Strategy for Non-IgE-Mediated Reactions Associated With Vancomycin.

Lyu S, Oliver ET, Dispenza MC, Chichester KL, Hoffman J, MacGlashan DW, Adkinson NF, Phillips EJ, Alvarez-Arango S. Lyu S, et al. Among authors: dispenza mc. J Allergy Clin Immunol Pract. 2024 Nov;12(11):3025-3033.e6. doi: 10.1016/j.jaip.2024.07.028. Epub 2024 Aug 6. J Allergy Clin Immunol Pract. 2024. PMID: 39117269

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters